The effects of Chinese herb Angelica in focal cerebral ischemia injury in the rat

Clinical Hemorheology and Microcirculation

Volumn 32, Issue 3, 2005, Pages 209-215

  Jing, Wei Yang ^a   Jing, Ping Ouyang ^a   Wei, Jing Liao ^b   Tian, Jun ^b   Yong, Ming Liu ^a   Wei, Lei ^a   Bao, Hua Wang ^a   Li, Ke ^a  

^a WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Angelica; Apoptosis; Bax; Bcl 2; Cerebral ischemia

Indexed keywords

ANGELICA EXTRACT; PROTEIN BAX; PROTEIN BCL 2; TRIPHENYLTETRAZOLIUM;

ANGELICA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN INFARCTION SIZE; BRAIN INJURY; BRAIN ISCHEMIA; CELL COUNT; CHINESE HERB; CONTROLLED STUDY; DRUG MECHANISM; IMMUNOHISTOCHEMISTRY; NERVE CELL; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; RAT; STATISTICAL SIGNIFICANCE;

ANGELICA; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BRAIN; BRAIN ISCHEMIA; COLORING AGENTS; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; ISCHEMIA; NEURONS; PHYTOTHERAPY; PLANT COMPONENTS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, WISTAR; TETRAZOLIUM SALTS;

EID: 21444450184     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. M. Barinaga, Stroke damaged neurons may commit cellular suicide, Science 281 (1998), 1302-1303.
2. S.I. Savitz and D.M. Rosenbaum, Apoptosis in neurological disease, Neurosurgery 42 (1998), 555-572.
3. S.A. Padosch, P. Vogel and B.W. Bottiger, Neuronal apoptosis following cerebral ischemia. Basis, physiopathology and treatment strategies, Anaesthesist 12 (2001), 905-920.
4. L.N. Xu, Pharmacology of Angelica, Editor: China Academy of Medical Science, Drugs Research Institut, Modern Research of Chinese Herbs, Vol. 2, Association publication: Beijing Medical University, China XIEHE Medical University Publish.
5. X. Wang, L. Wei, J.P. Ouyang, S. Muller, M. Gentils, G. Cauchois and J.F. Stoltz, Effects of an angelica extract on human erythrocyte aggregation, deformation and osmotic fragility, Clin. Hemorheol. Microcirc. 3 (2001), 201-205.
6. W. Wang, To contorl experimental conditions strictly and establish the standardized cerebral ischemia animal models, Journal China Neurology 5 (1998), 261-264.
7. W. Kuschinsky and F. Gillardon, Apoptosis and cerebral ischemia, Cerebrovasc. Dis. 3 (2000), 165-169.
8. K.A. Hossmann, Viability thresholds and the penumbra of focal ischemia, Ann. Neurol. 36 (1994), 557-565.
9. T. Kogure and K. Kogure, Molecular and biochemical events within the brain subjected to cerebral ischemia (targets for therapeutical intervention), Clin. Neurosci. 4 (1997), 179-183.
10. Y. Tsujimoto and S. Shimizu, Bcl-2 family: life-or-death switch, FEBS Lett. 1 (2000), 6-10 Related.
11. A. Gross, J.M. McDonnel and S.J. Korsmeyer, Bcl-2 family members and the mitochondria in apoptosis, Genes Dev. 13 (1999), 1899-1911.
12. W.R. Schabitz, C. Sommer and W. Zoder, Intravenous brain- derived neurotrophic factor reduces infarct size and counter-regulates Bax and Bcl-2 expression after temporary focal cerebral ischemia, Stroke 9 (2000), 2212-2217.
13. A. Wu, T. Ren and Q. Hu, Deltamethrin induces altered expression of P53, Bax and Bcl-2 in rat brain, Neurosci. Lett. 284(1-2) (2000), 29-32.